Building negative incentives into value-based insurance design programs to discourage use of low-value care will involve a number of challenges.
Dan Greenberg, PhD
Advertisement
Articles by Dan Greenberg, PhD
A systematic literature review from 1998 to 2003 showed that few cost-effectiveness analyses of self-administered medications model suboptimal medication adherence.
Advertisement
Latest Updated Articles
- Do Drug Formulary Policies Reflect Evidence of Value?
January 1st 2006
- Low-Value Services in Value-Based Insurance Design
April 7th 2010
- Patient Adherence: A Blind Spot in Cost-Effectiveness Analyses?
September 7th 2009
Advertisement
Advertisement
Trending on AJMC
1
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
2
Extension Studies in TPIP Show Promise in PAH, PH-ILD
3
Inhaled Amikacin Raises Culture Conversion in New MAC Lung Disease
4
Bronchiectasis GWAS Highlights Candidate Targets Shared With COPD
5